Back to SI Stephens Investment Management Group LLC
HALO
26 quarters
Position history for SIStephens Investment Management Group LLC's holdings in Halozyme Therapeutics, Inc.
Yes. Stephens Investment Management Group holds 1,413,040 shares of HALO (Halozyme Therapeutics), worth $156M, as of its Q3 2026 13F filing. It increased the position by 20,221 shares (+1.5%) from Q2 2026. Stephens Investment Management Group has held HALO since Q2 2020, across 26 quarterly 13F filings. HALO is 1.7% of Stephens Investment Management Group's reported 13F portfolio.
Current Value
$156M
Current Shares
1.4M
Total Value Change
+$151.3M
Total Shares Change
+1.2M
Quarter-by-Quarter History
Other major holders of HALO: BlackRock, Inc.